WO2012028816A1 - Utilisation d'un activateur de beta-glucosidase pour la détection et/ou l'identification de c.difficile - Google Patents
Utilisation d'un activateur de beta-glucosidase pour la détection et/ou l'identification de c.difficile Download PDFInfo
- Publication number
- WO2012028816A1 WO2012028816A1 PCT/FR2011/051982 FR2011051982W WO2012028816A1 WO 2012028816 A1 WO2012028816 A1 WO 2012028816A1 FR 2011051982 W FR2011051982 W FR 2011051982W WO 2012028816 A1 WO2012028816 A1 WO 2012028816A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- beta
- glucoside
- reaction medium
- difficile
- clostridium difficile
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/2445—Beta-glucosidase (3.2.1.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/045—Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01021—Beta-glucosidase (3.2.1.21)
Definitions
- the present invention relates to a method for detecting and / or identifying Clostridium difficile. It also relates to a specific reaction medium of Clostridium difficile comprising a beta-glucosidase activator.
- Clostridium difficile (C. difficile) is a gram-positive, strict anaerobic bacillus that forms spores. It causes intestinal pathologies of varying severity: medium or fulminant diarrhea, pseudomembranous colitis or toxic megacolon that may itself be the cause of sepsis. Clostridium difficile is transmitted by oral ingestion of spores that resist the acidity of the stomach and germinate in the intestine. An imbalance of the commensal flora of the colon allows the proliferation of C. difficile which produces toxins causing colitis. In many cases, the imbalance of the commensal flora is due to antibiotic use. C.
- C. difficile can be considered as a harmless microorganism of the environment, which becomes opportunistic pathogen under particular conditions.
- the asymptomatic gastrointestinal carriage of C. difficile is estimated at 3% in the adult population but can reach 15-25% of subjects after antibiotic treatment or a stay in a highly endemic unit.
- a high carriage rate is usually observed, from 20 to 40% in hospitalized patients up to 50-70% in young children.
- the possibility of early and rapid diagnosis is a key element for the prevention of severe complications, and for effective clinical management.
- the diagnosis is based on the search for toxins and the culture.
- Detection of toxins directly from stool is an excellent marker for the presence of a toxigenic strain of C. difficile.
- the reference method consists in searching for a cytopathic effect (CTA for cytotoxic activity according to the Anglo-Saxon name) by cell culture. This method is very sensitive but is not standardized and requires specialized technicians and a response time of several days. ELISA-type immunoenzymatic tests have also been developed, which detect either toxin A alone or toxins A and B. The time to obtain a result is reduced. However, it is recommended to combine the immunological techniques used for detecting toxins with bacterial culture to isolate strains of C. difficile. This culture can be implemented on a C. difficile agar marketed by the Applicant, the C.
- identification by gallery requires to have a pure culture of the bacterium to identify, on a suitable growth medium to obtain enough biomass (3 to 4 Me Farland) which takes, at best, 48h (isolation culture from 24 to 72 hours from the sample giving only the presumptive detection then culture from 24 to 72 hours to generate enough biomass).
- the gallery is then read after 4 hours of incubation for rapid ID 32 A and 24 to 48 hours for gallery 20A.
- the diagnosis can be made by molecular biology techniques. These techniques, however, are not used routinely to date.
- beta-glucosidase By its work with the aim of improving the direct identification of C. difficile, in a bacterial culture, the Applicant has demonstrated that the use of enzymatic substrate (s) beta-glucosidase allows easy identification and fast C. difficile. Said use of beta-glucosidase substrate is described in WO 2009/092982 as decreasing the time to obtain a C. difficile identification result.
- a reaction medium comprising a beta-glucosidase substrate and a beta- glucosidase activator of general formula Ar-beta-D-glucopyranoside, where Ar- corresponds to an aromatic nucleus or to several adjoined aromatic nuclei, allows rapid identification of C. difficile in a sample, that is, such a medium allows earlier detection of the enzymatic activity of at least some strains of C. difficile.
- an Ar-beta-D-glucoside compound allows activation of beta-glucosidase and the observation of a significantly higher staining of C. difficile colonies.
- the Ar-beta-D-glucoside compounds have an activating power of C. difficile beta-glucosidase much higher than that of other beta-D-glucoside derivatives such as cellobiose (4-O-beta-D-glucopyranosyl). -D-glucose) or Methyl-beta-D-glucose.
- the hydrolysis of arbutin to hydroquinone is a marker of the beta-glucosidase activity of Pseudomonas syringae (Hildebrand and Schroth, Applied Microbiology, 1964; 12 (6): 487-491). This deters a person skilled in the art from using an Ar-beta-D-glucoside compound as beta-glucosidase activator in a reaction medium for the detection or identification of C. difficile since it would be in competition with the substrate. intended to reveal the enzymatic activity of the target microorganism.
- reaction medium is meant a medium comprising all the elements necessary for the expression of a metabolism and / or the growth of microorganisms.
- the reaction medium may be solid, semi-solid or liquid.
- solid medium is meant for example a gelled medium.
- Agar is the traditional gelling agent in microbiology for the cultivation of microorganisms, but it is possible to use gelatin, agarose or other natural or artificial gelling agents.
- a number of preparations are commercially available, such as Columbia agar, Trypcase-soy agar, Mac Conkey agar, Sabouraud agar or more generally those described in the Handbook of Microbiological Media (CRC Press).
- the reaction medium according to the invention must allow the growth of C. difficile.
- the reaction medium may comprise one or more elements in combination, such as amino acids, peptones, carbohydrates, nucleotides, minerals, vitamins, etc.
- the medium may also comprise a dye.
- dye of Evans blue, neutral red, sheep blood, horse blood, an opacifier such as titanium oxide, nitroaniline, malachite green, brilliant green , one or more metabolic indicators, one or more metabolic regulators ...
- the reaction medium may be a revelation medium or a culture and revelation medium.
- the culture of the microorganisms is carried out before seeding, and in the second case, the detection and / or identification medium also constitutes the culture medium.
- the detection and / or identification medium also constitutes the culture medium.
- Those skilled in the art can also use a bi-box, which makes it easy to compare two media, comprising different substrates or different selective mixtures, on which a same biological sample has been deposited.
- the reaction medium may comprise one or more growth promoters for C. difficile strains.
- growth promoter is meant a compound or a group of compounds that stimulates the growth of microorganisms. These include blood, serum, egg yolk. Without being limiting, a concentration of between 0.1 and 10% is particularly suitable for the present invention.
- the reaction medium may comprise one or more reducing agents.
- reducing agent is meant a compound or a group of compounds which facilitates the growth of anaerobic germs by neutralizing the dissolved oxygen present in the medium. Cysteine, Pyruvate, Oxyrase, Sulfite Sodium, Dithionite, Histidine, Ferrous Sulfide may be mentioned in particular.
- a concentration of between 0.05 and 50 g / l, preferably between 0.1 and 2 g / l is particularly suitable for the present invention.
- the reaction medium may comprise one or more inducers of C. difficile spore germination.
- inducer of spore germination is meant a compound or a group of compounds that promotes the passage from the spore state to the vegetative state of C. difficile.
- Sodium Taurocholate may be mentioned in particular.
- a concentration of between 0.1 and 10 g / l, preferably between 1 and 5 g / l is particularly suitable for the present invention.
- the reaction medium may comprise one or more selective agents.
- selective agent is meant any compound capable of preventing or slowing the growth of a microorganism other than the target microorganism. Without being limiting, a concentration of between 5 mg / l and 5 g / l is particularly suitable for the present invention.
- antibiotics and antifungals are examples of antibiotics and antifungals.
- antibiotic is meant any compound capable of preventing or slowing the growth of a bacterium. They belong in particular to the groups of cephalosporins, aminoglycosides, polypeptides, sulphonamides, quinolones.
- antifungal any compound that can prevent or slow the growth of yeast or mold.
- amphotericin B fluconazole, itraconazole, voriconazole, cycloheximide.
- the reaction medium may additionally contain a substrate enabling the detection of an enzymatic or metabolic activity of the target microorganisms by means of a directly or indirectly detectable signal.
- this substrate may be bound to a marker portion, fluorescent or chromogenic.
- the reaction medium according to the invention may additionally comprise a pH indicator, sensitive to the pH variation induced by the consumption of the substrate and revealing the growth of the target microorganisms.
- the said pH indicator may be a chromophore or a fluorophore.
- chromophores include neutral red, aniline blue, bromocresol blue.
- the fluorophores include, for example, 4-methylumbelliferone, hydroxycoumarin derivatives or resorufin derivatives.
- beta-glucosidase substrate suitable for the identification of C. difficile is meant a substrate which, under suitable growth conditions, induces the coloration of C. difficile.
- 2-hydroxyphenyl beta glucoside (Catechol-beta glucoside) is used; Magenta-beta glucoside (5-Bromo-6-chloro-3 indoxyl-beta glucoside); DHF-beta glucoside (Dihydroxyflavone-beta glucoside); Esculin (Esculetin-beta glucoside); CHE-beta glucoside (3,4 Cyclohexenesculetin-beta glucoside); 8 Hydroxiquinoline-beta glucoside; X-beta glucoside (5-Bromo-4-chloro-3 indoxyl-beta glucoside); Rose-beta glucoside (6 Chloro-3 indoxyl-beta glucoside); 6
- the reaction medium may further comprise an enzymatic activator.
- enzymatic activator is meant a compound which serves to activate the enzymatic digestion process, ie to reduce the incubation time to reveal the enzymatic activity and / or to increase said enzymatic activity.
- the beta-glucosidase activators according to the invention have the general formula Ar-beta-D-glucoside, where Ar- represents an aromatic ring.
- aromatic ring is meant an unsaturated compound, that is to say having double bonds and having one or more contiguous rings, homo- or hetero-atomic, each ring having from 5 to 7 vertices.
- Non-limiting examples are arbutin (hydroquinone-beta-D-glucoside), 4-methylumbelliferyl-beta-glucoside, 4-aminophenyl-beta-glucoside, and salicine (2- (hydroxymethyl) -phenyl-beta).
- D-glucoside D-glucoside
- esculin (6,7-dihydroxy-coumarin-beta-glucoside).
- Some of these compounds are substrates for beta-glucosidase. According to the invention, they are considered as activators because they make it possible to reduce the incubation time necessary for the detection of the hydrolysis of the compound used as substrate, or they make it possible to increase this hydrolysis.
- the combination of an enzymatic substrate and an activator according to the invention makes it possible to have an earlier and / or more intense detection of the enzymatic activity when these compounds are used separately.
- the activating power of a compound can in particular be demonstrated for certain strains of C. difficile having a late and / or weak beta-glucosidase activity, if the combination of said compound and the substrate allows an earlier and / or more intense detection. if the substrate or the activator was used alone at a molarity at least equivalent to the sum of the molarities of the substrate and the activator in combination.
- Biological sample means a small or small amount isolated from an entity for analysis. It can be a clinical sample, from a sample of biological fluid or a food sample, from any type of food. This sample can be liquid or solid. There may be mentioned in a nonlimiting manner, a clinical sample of whole blood, serum, plasma, urine, faeces, nose samples, throats, skin, wounds, cerebrospinal fluid, a food sample of water, beverages such as milk, fruit juice, yogurt, meat, eggs, vegetables, mayonnaise, cheese; fish ..., a food sample from a feed intended for animals, such as in particular a sample from animal meal. This sample may be used as it is or, prior to the analysis, undergo an enrichment-type preparation, extraction, concentration, purification, according to methods known to those skilled in the art.
- the reaction medium After contacting the sample, the reaction medium is incubated at an appropriate temperature, generally between 20 and 50 ° C, preferably between 30 and 40 ° C. Preferably, the incubation is performed anaerobically, in other words in the absence of oxygen, according to techniques known to those skilled in the art.
- the invention relates to a reaction medium comprising at least one beta-glucosidase substrate, and a compound of the general formula Ar-beta-D-glucoside, wherein Ar- denotes an aromatic compound, different from said substrate, at a concentration less than 5 g / l.
- the compound Ar-beta-D-glucoside is at a concentration of between 0.3 and 1.5 g / l.
- the compound of formula Ar-beta-D-glucoside is chosen from arbutin or hydroquinone-beta-glucoside, 4-methylumbelliferyl-beta-glucoside, 4-aminophenyl-beta- glucoside, salicin or - (hydroxymethyl) phenyl-beta-D-glucoside, esculin or 6,7-dihydroxy-coumarin-beta-glucoside.
- the compound Ar-beta-D-glucoside is arbutin.
- the beta-glucosidase substrate is chosen from Alizarin-beta-glucoside, Magenta-beta-glucoside (5-Bromo-6-chloro-3-indoxyl-beta-glucoside ), DHF-beta-glucoside, 3HF-beta-glucoside, CHE-beta-glucoside (3,4-cyclohexenoesculetin-beta- glucoside) and ALDOL TM -beta-glucoside from BIOSYNTH (Wick et al. 2009. ASM General meeting - Philadelphia (PA, USA)).
- Said beta-glucosidase substrate is at a concentration of between 25 and 1000 mg / l, preferably between 50 and 400 mg / l.
- the enzymatic activator is an enzymatic substrate whose hydrolysis product is different from the product of the hydrolysis of the enzymatic substrate.
- the enzymatic activator is an enzymatic substrate whose product is not detectable to the naked eye in the reaction medium, whereas the product of the hydrolysis of the enzymatic substrate is.
- the reaction medium further comprises a C. difficile spore germination activator, said activator being preferentially sodium taurocholate, at a concentration of between 0.1 and 10, 0 g / l, preferably between 1.0 and 5.0 g / l.
- the invention also relates to a method for detecting and / or identifying C. difficile comprising the steps of:
- the method according to the invention implements in step a) a medium as defined above.
- the incubation implemented in step b) of the process according to the invention is carried out anaerobically.
- the invention finally relates to the use of a compound of the general formula Ar-beta-D-glucoside as a beta-glucosidase activator in a reaction medium.
- said compound is at a concentration of less than 5 g / l, preferably between 0.3 and 1.5 g / l.
- said compound is chosen from: arbutin or hydroquinone-beta-glucoside, 4-methylumbelliferyl-beta-glucoside, 4-aminophenyl-beta-glucoside, salicin or 2- (hydroxymethyl) phenylbeta-glucoside. D-glucoside, esculin or 6,7-dihydroxy-coumarin-beta-glucoside. More preferably, said compound is arbutin.
- said reaction medium is a C. difficile detection and / or identification medium.
- Example 1 Demonstration of the activating effect of arbutin on a beta-glucosidase substrate.
- Clostridium difficile Eight strains of Clostridium difficile, from the Applicant's collection, were tested on media comprising arbutin at different concentrations in the presence or absence of CHE-beta-glucoside. The reading of the boxes is then carried out at 24 hours.
- the circles are composed as follows:
- ChromlD® C. difficile base common to all environments
- the media are divided into petri dishes.
- Seeding is performed from pre-cultures of 48h at 37 ° C under anaerobic conditions.
- Readings are performed after 24h of incubation at 37 ° C. under anaerobic conditions.
- ⁇ 4 presence of a very intense coloring.
- the coloration obtained with this substrate is gray to an intensity of 1 and black for the other values.
- Arbutin acts as a beta-glucosidase activator on Clostridium difficile strains.
- Example 2 Testing an optimal arbutin concentration on different strains of C. difficile.
- Clostridium difficile Twenty four strains of Clostridium difficile, from the Applicant's collection, were tested on 5 media each comprising a different concentration of arbutin. The reading of the boxes is then carried out at 24 hours.
- the media used are prepared on the basis of chromlD® C. difficile medium indicated above, for example 1, to which are added respectively cefotaxime 0.016 g / l, fungizone 0.005 g / l and D- cycloserine at 0.25 g / l (final concentrations), and arbutin according to the following table:
- the media are divided into petri dishes.
- Seeding is performed from pre-cultures of 48h at 37 ° C under anaerobic conditions.
- Readings are performed after 24 hours of anaerobic incubation.
- the coloration obtained with this substrate is gray to an intensity of 1 and black for the other values.
- strains already having a strong staining on the control do not seem or little impacted by the presence of arbutin if one does not exceed 1g / L. Beyond this, some strains show a slight decrease in color intensity.
- Arbutin acts well here as a beta-glucosidase activator and its action seems significant for the early detection of Clostridium difficile and in particular for ribotype 027.
- Example 3 Testing the activating effect of arbutin on various beta-glucosidase substrates.
- Example 1 ENVIRONMENT AND MICROORGANISMS The eight strains of Clostridium difficile tested in Example 1 were tested on media comprising DHF-beta-glucoside (media A), alizarin-beta-glucoside (media B) or 3HF-beta-glucoside ( C media) and an increasing concentration of arbutin.
- the media used are prepared on the basis of chromlD® C. difficile media indicated above, for example 1, to which arbutin is added according to the following table:
- the media are therefore as follows:
- the media are divided into petri dishes.
- Seeding is performed from pre-cultures of 48h at 37 ° C under anaerobic conditions.
- Readings are carried out after 24h and 48h of incubation at 37 ° C. and in anaerobiosis.
- Example 4 Test of the activating effect of the Ar-beta-glucoside compounds on the beta-glucosidase activity. 1. ENVIRONMENT AND MICROORGANISMS
- the media used are prepared on the basis of chromlD® C. difficile medium indicated above for Example 1, to which is added the substrate CHE-beta-glucoside at 0.3 g / l and, respectively, one of the compounds according to following table:
- the media are divided into petri dishes.
- Seeding is performed from pre-cultures of 48h at 37 ° C under anaerobic conditions.
- Readings are performed after 24h incubation at 37 ° C and anaerobiosis.
- the coloration obtained with this substrate is gray to an intensity of 1 and black for the other values.
- O-methyl-beta-glucoside and cellobiose have no activating effect on Clostridium difficile beta -glucosidase. On the contrary, there is a decrease in staining on strains staining on the control.
- CONCLUSION This test demonstrates the activating effect of C. difficile beta -glucosidase by compounds having at least one aromatic ring such as arbutin, salicin, 4-aminophenyl-beta- glucoside, 4-methyl-umbelliferone or esculin.
- Clostridium difficile Eight strains of Clostridium difficile were tested on 4 different media, respectively growth control medium (T), medium (1) containing 75 mg / L of ALDOL TM 455-beta-glucoside, medium (2) containing 75 mg / L in ALDOL TM 484-beta-glucoside, and a medium (3) containing CHE-b-glucoside at a rate of 300 mg / L and ammonium iron citrate (300 mg / L).
- T growth control medium
- medium (2) containing 75 mg / L in ALDOL TM 484-beta-glucoside
- a medium (3) containing CHE-b-glucoside at a rate of 300 mg / L and ammonium iron citrate (300 mg / L).
- composition of the nutrient base common to all media is shown below. It is chromlD® C. difficile base free of ammonia iron citrate but supplemented with 1 arbutin.
- the base After melting of the agars, the base is separated into 4 * 80mL, distributed in the bottles T, 1, 2 and 3.
- the bottle 3 we have previously weighed 300mg / L of CHE-beta-glucoside and 300mg / L of ammonia iron citrate.
- An autoclave cycle sterilizes the media.
- substrates based on ALDOL TM are added additives, solubilized in a DMSO-type solvent (dimethylsulfoxide), from a concentrated stock solution. 2.
- DMSO-type solvent dimethylsulfoxide
- the media are divided into petri dishes.
- Seeding is performed from pre-cultures of 48h at 37 ° C under anaerobic conditions.
- the stains of the isolated colonies obtained on the media 1, 2 and 3 are respectively yellow, orange and brown.
- ALDOL TM 455-beta-glucoside and ALDOL TM 484-beta-glucoside (BIOSYNTH) substrates provide excellent C. difficile detection.
- the intensities of colorations (yellow and orange respectively) obtained are high, and this from 24h incubation.
- the performances obtained with these two substrates are substantially identical to those obtained with CHE-beta-glucoside.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201180041835.6A CN103080299B (zh) | 2010-09-01 | 2011-08-30 | β‑葡糖苷酶激活剂用于检测和/或鉴定难辨梭菌的用途 |
EP11764808.9A EP2611903B1 (fr) | 2010-09-01 | 2011-08-30 | Utilisation d'un activateur de beta-glucosidase pour la détection et/ou l'identification de c.difficile |
US13/816,135 US20130137126A1 (en) | 2010-09-01 | 2011-08-30 | Use of a beta-glucosidase activator for the detection and/or identification of c. difficile |
ES11764808.9T ES2607629T3 (es) | 2010-09-01 | 2011-08-30 | Utilización de un activador de beta-glucosidasa para la detección y/o la identificación de C. Difficile |
JP2013526532A JP5882330B2 (ja) | 2010-09-01 | 2011-08-30 | C.difficileを検出および/または同定するための、β−グルコシダーゼ活性化剤の使用 |
AU2011298206A AU2011298206B2 (en) | 2010-09-01 | 2011-08-30 | Use of a beta-glucosidase activator for detecting and/or identifying C. difficile |
BR112013004337-7A BR112013004337B1 (pt) | 2010-09-01 | 2011-08-30 | meio reacional que compreende um substrato de beta-glicosidase e um ativador de beta-glicosidase e processo de detecção e/ou identificação de clostridium difficile |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1056928 | 2010-09-01 | ||
FR1056928A FR2964116B1 (fr) | 2010-09-01 | 2010-09-01 | Utilisation d'un activateur de beta-glucosidase pour la detection et/ou l'identification de c.difficile |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012028816A1 true WO2012028816A1 (fr) | 2012-03-08 |
Family
ID=43530592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2011/051982 WO2012028816A1 (fr) | 2010-09-01 | 2011-08-30 | Utilisation d'un activateur de beta-glucosidase pour la détection et/ou l'identification de c.difficile |
Country Status (9)
Country | Link |
---|---|
US (1) | US20130137126A1 (fr) |
EP (1) | EP2611903B1 (fr) |
JP (1) | JP5882330B2 (fr) |
CN (1) | CN103080299B (fr) |
AU (1) | AU2011298206B2 (fr) |
BR (1) | BR112013004337B1 (fr) |
ES (1) | ES2607629T3 (fr) |
FR (1) | FR2964116B1 (fr) |
WO (1) | WO2012028816A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108431208A (zh) * | 2015-12-03 | 2018-08-21 | 朗泽科技新西兰有限公司 | 增补精氨酸以改善气体发酵产乙酸菌的效率 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6911660B2 (ja) * | 2017-09-13 | 2021-07-28 | Jnc株式会社 | クロストリジウム属細菌選択分離用培地 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998045469A1 (fr) * | 1997-04-10 | 1998-10-15 | Dade Microscan Inc. | Systemes d'analyse universels et leurs procedes d'utilisation pour identifier diverses familles de micro-organismes |
US20070004021A1 (en) * | 2004-06-28 | 2007-01-04 | Lawrence Restaino | Plating media for the identification of Yersinia pestis |
FR2912423A1 (fr) * | 2007-02-08 | 2008-08-15 | Biomerieux Sa | Milieu de detection et/ou d'identification de bacteries |
FR2926563A1 (fr) * | 2008-01-21 | 2009-07-24 | Biomerieux Sa | Procede de detection et/ou d'identification de clostridium difficile |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3761236B2 (ja) * | 1995-12-20 | 2006-03-29 | 天野エンザイム株式会社 | 新規なβ−グルコシダーゼ、その製造法および用途 |
JP3796809B2 (ja) * | 1996-05-01 | 2006-07-12 | 大日本インキ化学工業株式会社 | フェノール系配糖体、及びその製造方法 |
US6013635A (en) * | 1998-05-28 | 2000-01-11 | Synsorb Biotech, Inc. | Treatment of C. difficile toxin B associated conditions |
WO2002026979A1 (fr) * | 2000-09-29 | 2002-04-04 | Meiji Seika Kaisha, Ltd. | NOUVELLE ENZYME PRESENTANT UNE ACTIVITE β-GLUCOSIDASE ET SON UTILISATION |
JP2009034028A (ja) * | 2007-08-01 | 2009-02-19 | Hayashibara Biochem Lab Inc | β−グルコシダーゼ及びその製造方法並びにそれを利用したβ型配糖体の製造方法 |
-
2010
- 2010-09-01 FR FR1056928A patent/FR2964116B1/fr active Active
-
2011
- 2011-08-30 EP EP11764808.9A patent/EP2611903B1/fr active Active
- 2011-08-30 US US13/816,135 patent/US20130137126A1/en not_active Abandoned
- 2011-08-30 CN CN201180041835.6A patent/CN103080299B/zh active Active
- 2011-08-30 JP JP2013526532A patent/JP5882330B2/ja active Active
- 2011-08-30 WO PCT/FR2011/051982 patent/WO2012028816A1/fr active Application Filing
- 2011-08-30 BR BR112013004337-7A patent/BR112013004337B1/pt active IP Right Grant
- 2011-08-30 ES ES11764808.9T patent/ES2607629T3/es active Active
- 2011-08-30 AU AU2011298206A patent/AU2011298206B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998045469A1 (fr) * | 1997-04-10 | 1998-10-15 | Dade Microscan Inc. | Systemes d'analyse universels et leurs procedes d'utilisation pour identifier diverses familles de micro-organismes |
US20070004021A1 (en) * | 2004-06-28 | 2007-01-04 | Lawrence Restaino | Plating media for the identification of Yersinia pestis |
FR2912423A1 (fr) * | 2007-02-08 | 2008-08-15 | Biomerieux Sa | Milieu de detection et/ou d'identification de bacteries |
FR2926563A1 (fr) * | 2008-01-21 | 2009-07-24 | Biomerieux Sa | Procede de detection et/ou d'identification de clostridium difficile |
WO2009092982A2 (fr) | 2008-01-21 | 2009-07-30 | bioMérieux | Procédé de détection et/ou d'identification de clostridium difficile |
Non-Patent Citations (9)
Title |
---|
"Handbook of Microbiological Media", CRC PRESS |
GILBRETH STEFANIE EVANS ET AL: "Catabolite repression and virulence gene expression in Listeria monocytogenes.", CURRENT MICROBIOLOGY AUG 2004 LNKD- PUBMED:15297913, vol. 49, no. 2, August 2004 (2004-08-01), pages 95 - 98, XP002621317, ISSN: 0343-8651 * |
HILDEBRAND D C ET AL: "beta-Glucosidase Activity in Phytopathogenic Bacteria.", APPLIED MICROBIOLOGY NOV 1964 LNKD- PUBMED:16349648, vol. 12, no. 6, November 1964 (1964-11-01), pages 487 - 491, XP002621316, ISSN: 0003-6919 * |
HILDEBRAND, SCHROTH, APPLIED MICROBIOLOGY, vol. 12, no. 6, 1964, pages 487 - 491 |
LUKAS M. WICK, ALEXANDER BAYER, CHRISTOPHE WEYMUTH, GÜNTER SCHABERT, VANESSA PFISTER, AYSEL ASLAN, URS P. SPITZ: "Novel Chromogenic Enzyme Substrates", ASM GENERAL MEETING, 2009 |
SCHINDLER ET AL., J . CLIN. PHARMACOL., vol. 42, no. 8, 2002, pages 920 - 927 |
SIEGERS ET AL., PHYTOMEDICINE, vol. 10, no. 4, 2003, pages 58 - 60 |
WICK ET AL., ASM GENERAL MEETING - PHILADELPHIA, 2009 |
WILSON K H ET AL: "Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile.", JOURNAL OF CLINICAL MICROBIOLOGY MAR 1982 LNKD- PUBMED:7076817, vol. 15, no. 3, March 1982 (1982-03-01), pages 443 - 446, XP002621318, ISSN: 0095-1137 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108431208A (zh) * | 2015-12-03 | 2018-08-21 | 朗泽科技新西兰有限公司 | 增补精氨酸以改善气体发酵产乙酸菌的效率 |
Also Published As
Publication number | Publication date |
---|---|
EP2611903A1 (fr) | 2013-07-10 |
CN103080299A (zh) | 2013-05-01 |
ES2607629T3 (es) | 2017-04-03 |
JP2013536680A (ja) | 2013-09-26 |
AU2011298206A8 (en) | 2013-05-02 |
BR112013004337A2 (pt) | 2016-05-31 |
JP5882330B2 (ja) | 2016-03-09 |
AU2011298206A1 (en) | 2013-04-11 |
CN103080299B (zh) | 2017-03-22 |
FR2964116B1 (fr) | 2017-06-02 |
BR112013004337B1 (pt) | 2019-11-12 |
US20130137126A1 (en) | 2013-05-30 |
AU2011298206B2 (en) | 2015-08-13 |
EP2611903B1 (fr) | 2016-10-05 |
FR2964116A1 (fr) | 2012-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1546366B1 (fr) | Procede de detection et de comptage de microorganismes dans un echantillon | |
WO2008104681A2 (fr) | Milieu de détection et/ou d'identification de bactéries | |
EP2235202B1 (fr) | Procédé de détection et/ou d'identification de clostridium difficile | |
WO2008104680A2 (fr) | Milieu de détection et/ou d'identification de bactéries | |
EP2877591B1 (fr) | Procede de detection de bacteries productrices de carbapenemases de type oxa-048 | |
EP2611903B1 (fr) | Utilisation d'un activateur de beta-glucosidase pour la détection et/ou l'identification de c.difficile | |
EP3094738B1 (fr) | Utilisation d'au moins un substrat de carboxylestérase et/ou de triacylglycérol-lipase pour la détection des bactéries du groupe bacillus cereus | |
FR2924127A1 (fr) | Milieu reactionnel pour la detection et/ou l'identification de staphyloccocus aureus | |
EP2981619A1 (fr) | Utilisation d'au moins un substrat de phosphatase chromogène et/ou fluorogène pour la détection et/ou le dénombrement d'entérobactéries dans un échantillon | |
EP2205976A2 (fr) | Test biochimique pour confirmer la presence de l. monocytogenes | |
WO2013107994A1 (fr) | Detection in vitro de microorganismes presentant une activite azoreductase | |
CN102482707B (zh) | 硝基还原酶的新型酶底物 | |
CN102482708B (zh) | 硝基还原酶的新型酶底物 | |
WO2011012823A2 (fr) | Nouveaux substrats enzymatiques de nitroreductase | |
EP2785857A1 (fr) | Milieu et procede de detection de bacteries yersinia enterocolitica pathogenes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201180041835.6 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11764808 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13816135 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2013526532 Country of ref document: JP Kind code of ref document: A |
|
REEP | Request for entry into the european phase |
Ref document number: 2011764808 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011764808 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2011298206 Country of ref document: AU Date of ref document: 20110830 Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112013004337 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112013004337 Country of ref document: BR Kind code of ref document: A2 Effective date: 20130225 |